期刊文献+

胰腺肿瘤的多学科诊疗模式 被引量:8

Multidisciplinary management of pancreatic neoplasms
原文传递
导出
摘要 胰腺肿瘤发病隐匿、解剖复杂,诊治较为困难。随着医学的发展,多学科诊疗模式(muhidisci-plinaryteam,MDT)逐渐成为胰腺肿瘤诊治的重要方式。本文从MDT的概念出发,通过总结MDT在国内外的发展历史。探讨MDT在胰腺肿瘤诊治中的重要价值,分享MDT的具体实施经验,以期进一步提高我国胰腺肿瘤的多学科诊疗水平,改善我国胰腺肿瘤患者的预后。 Pancreatic neoplasms have characteristics of indiscoverable growth and complex anatomy, which lead to difficulties of diagnosis and treatment. With the development of medicine, muhidisciplinary team has become increasingly prevalent in the management of pancreatic neoplasms. In the paper, the definition of muhidisciplinary team, domestic and international development of multidisciplinary management, the value of muhidisciplinary management in pancreatic neoplasms, and our experiences of muhidisciplinary management are discussed to further improve the level of muhidisciplinary management and prognosis of patients with pancreatic neoplasms in China.
作者 崔铭 廖泉 赵玉沛 Cui Ming, Liao Quan, Zhao Fupei(Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences & Peking Union Medical College, Beijing 100730, Chin)
出处 《中华内分泌外科杂志》 CAS 2017年第6期441-443,共3页 Chinese Journal of Endocrine Surgery
基金 国家自然科学基金(81673023)
关键词 胰腺肿瘤 多学科诊疗 Pancreatic neoplasms Muhidisciplinary team
  • 相关文献

参考文献5

二级参考文献23

  • 1Callery MP,Chang KJ,Fishman EK,et al.Pretreatment assessment of resectable and borderline resectable pancreatic cancer:expert consensus statement.Ann Surg Oncol,2009,16:1727-1733.
  • 2Katz MH,Pisters PW,Evans DB,et al.Borderline resectable pancreatic cancer:the importance of this emerging stage of disease.J Am Coll Surg,2008,206:833-846.
  • 3Gillen S,Schuster T,Meyer Zum Büschenfelde C,et al.Preoperative/neoadjuvant therapy in pancreatic cancer:a systematic review and meta-analysis of response and resection percentages.PLoS Med,2010,7:e1000267.
  • 4Hidalgo M.Pancreatic cancer.N Engl J Med,2010,362:1605-1617.
  • 5Müller SA,Hartel M,Mehrabi A,et al.Vascular resection in pancreatic cancer surgery:survival determinants.J Gastrointest Surg,2009,13:784-792.
  • 6Tseng JF,Raut CP,Lee JE,et al.Pancreaticoduodenectomy with vascular resection:margin status and survival duration.J Gastrointest Surg,2004,8:935-949.
  • 7Conroy T,Desseigne F,Ychou M,et al.Randomized phase Ⅲ trial comparing FOLFIRINOX (F:5FU/leucovorin[LV] ,irinotecan[I] ,andoxaliplatin[O] ) versus gemcitabine (G) as first-line treatment for metastaticpancreatic adenocarcinoma (MPA):Preplanned interim analysis results of the PRODIGE 4/ACCORD 11 trial.J Clin Oncol,2010,28:4010.
  • 8Neoptolemos JP,Stocken DD,Bassi C,et al.Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection:a randomized controlled trial.JAMA,2010,304:1073-1081.
  • 9赵玉沛.胰腺癌诊治指南[J].中国实用外科杂志,2007,27(9):671-673. 被引量:48
  • 10Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014, CA [J].Can- cer J Clin,2014,64(1):9-29.

共引文献114

同被引文献95

引证文献8

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部